Search Results

Displaying Results 1-4 of 4 "'LGL'"

Aug 23, 2026, 21:54 ET Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics

Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California.

More news about: Rznomics


Mar 10, 2026, 07:00 ET Samsung Biologics Announces Collaboration with Lilly to Establish New Gateway Labs Site in Korea

development and manufacturing organization (CDMO), announced a collaboration agreement with Eli Lilly and Company (Lilly) to establish a Lilly Gateway Labs (LGL) site in Korea.

More news about: Samsung Biologics


Nov 19, 2025, 06:45 ET Lilly announces plans to open Lilly Gateway Labs site in Philadelphia

Nov. 19, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to open a new Lilly Gateway Labs (LGL) site in Philadelphia, bringing its distinctive model of scientific partnership to a city known for shaping the future of medicine.

More news about: Eli Lilly and Company


Sep 26, 2025, 08:30 ET Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem

Square Megacampus in Torrey Pines. LGL San Diego features 82,514 square feet of flexibly designed laboratory and office space to accommodate up to 15 life sciences companies and more than 250 employees of LGL-based companies.  "At Lilly, we are committed to meeting

More news about: Eli Lilly and Company


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.